Target intelligence / Profile preview

Lipopolysaccharide core antigen of Gram-negative bacteria (LPS core antigen)

Target
LPS core antigen
Molecular classification
Other, Bacterial antigen, Glycolipid
01

Overview

The lipopolysaccharide (LPS) core antigen is a conserved oligosaccharide region within the LPS molecule found on the outer membrane of all Gram-negative bacteria. The LPS consists of three regions: the lipid A anchor (the main endotoxin moiety), the core oligosaccharide (the "core antigen," attached to lipid A), and the distal O-antigen polysaccharide (highly variable and species-specific). The core region typically comprises a short array of unusual sugars (such as Kdo and heptoses) and is less variable than the O-antigen, making it an important cross-reactive antigenic target for immunodiagnostics and potential broad-spectrum Gram-negative vaccines. Functionally, the LPS core antigen is essential for maintaining membrane integrity, repelling harmful substances, and resisting host immune defenses. It also serves as a key antigenic marker for laboratory classification and serotyping of bacterial strains and species. When released during infection or bacterial lysis, LPS fragments with the core antigen can trigger severe innate immune responses, leading to fever, inflammation, or septic shock.

Other names
LPS core oligosaccharideCore region of lipopolysaccharideLipooligosaccharide (when O-antigen is missing, though this usually refers to a truncated LPS structure)Endotoxin core antigen (colloquial)
02

Mechanism of action

Outer membrane disruption: Drugs like polymyxins bind to the LPS core and lipid A, destabilizing the outer membrane and killing bacteria. Endotoxin neutralization: Experimental therapeutics (antibodies, peptides) may neutralize LPS or its core region to block inflammation.

03

Biological functions

Maintenance of outer membrane structural integrity in Gram-negative bacteriaBarrier to antibiotics and toxic compoundsFacilitation of immune evasion (structure variability helps bacteria avoid host immune recognition)Activation of innate immunity via release and recognition as endotoxin by host pattern recognition receptors like TLR4Basis for serotyping of bacteria in diagnostics
04

Disease associations

Infection (major component in the pathogenesis of Gram-negative bacterial infections)Inflammation (LPS fragments can trigger a strong inflammatory response, including sepsis and endotoxic shock)Other (acts as a biomarker for Gram-negative bacteremia)
05

Safety considerations

High immunogenicity and endotoxin activity: Release into host tissues can cause toxic shockHigh structural variability: hinders the development of broad-spectrum vaccines or therapeuticsPotential cross-reactivity: between related core antigens of different species.
06

Interacting drugs

Polymyxin B (binds LPS core and lipid A, disrupting the outer membrane)

2 more in the full profile.

07

Biomarkers

Core-specific antibodies (used for serotyping and detecting Gram-negative infections)Endotoxin/LPS detection assays (for diagnosis of Gram-negative sepsis)

Beyond the preview

Go deeper on Lipopolysaccharide core antigen of Gram-negative bacteria (LPS core antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide core antigen of Gram-negative bacteria (LPS core antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call